Breaking News

The pathobiology and treatment of mucus plugs in asthma and COPD: state of the art Eosinófilos para acortar la corticoterapia en la exacerbación asmáticaUna estrategia prometedora pendiente de confirmación Cambio a depemokimab cada seis meses en pacientes con asma grave previamente tratados con mepolizumab o benralizumab Early Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort Study Association between overuse of short-acting β2-agonists and the risk of major adverse cardiovascular events among patients with asthma

benralizumab

Subscribe to this category

030

Remisión clínica mantenida durante dos años con benralizumab en el asma eosinofílica grave: Estudio XALOC-1

Remisión clínica mantenida durante dos años con benralizumab en el asma eosinofílica grave: Estudio XALOC-1

22 diciembre, 2025 Like 0 Revisiones Asma

Clinical Remission Over 2 Years With Benralizumab in Severe Eosinophilic Asthma...

Leer más

027

Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype

Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype

18 diciembre, 2024 Like 0 Revisiones Asma

Artículo selecciondo: David J. Jackson, Ph.D., Michael E. Wechsler, M.D., Danie..

Leer más

027

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme

18 diciembre, 2024 Like 0 Revisiones Asma

Articulo seleccionado: Jackson D, Pelaia G, Emmanuel B, et al. Benralizumab in s..

Leer más

027

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.

18 diciembre, 2024 Like 0 Revisiones Asma

Artículo seleccionado: Sanjay Ramakrishnan, Richard E K Russell, Hafiz R Mahmoo..

Leer más

Categorías